This inventor holds 4 USPTO granted patents. Top assignee: Other. Active years: 2006-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 834,513 Years Active: 2006-2010
Title: Michael F Verderame: Innovator in Opioid Growth Factor Research
Introduction
Michael F Verderame is a notable inventor based in Hershey, PA (US). He has made significant contributions to the field of biomedical research, particularly in the area of opioid growth factor treatment. With a total of 4 patents to his name, Verderame's work focuses on innovative methods for cell cycle control and modulation of cell growth.
Latest Patents
One of his latest patents is titled "Cyclin-dependent kinase inhibitors as targets for opioid growth factor treatment." This invention provides methods for controlling the cell cycle by administering opioid growth factor (OGF), which activates opioid growth factor receptor (OGFr) signaling. The patent outlines a method for monitoring OGF modulation or treatment of conditions related to cell proliferation by assessing the levels of cyclin-dependent kinase inhibitors (CKIs). Additionally, it includes a method for screening subjects for OGF treatment eligibility by evaluating OGF receptor levels and relevant CKIs. Another significant patent is focused on "Opioid growth factor receptors," which relates to novel nucleic acid molecules coding for these receptors. This invention includes isolated nucleic acid molecules for human and rat OGF receptors, as well as methods for modulating cell growth using these molecules.
Career Highlights
Throughout his career, Michael F Verderame has demonstrated a commitment to advancing scientific knowledge and therapeutic applications in his field. His innovative approaches have the potential to impact treatments for various growth-related conditions.
Collaborations
Michael has collaborated with esteemed colleagues such as Ian S Zagon and Patricia J McLaughlin. Their combined expertise has contributed to the development of groundbreaking research and patents in the realm of opioid growth factors.
Conclusion
Michael F Verderame is a distinguished inventor whose work in opioid growth factor research has led to significant advancements in biomedical science. His contributions continue to influence the field and offer promising avenues for future research and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile